Literature DB >> 17846128

Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.

Ruiru Shi1, Jianyuan Zhang, Koji Otomo, Guolong Zhang, Isamu Sugawara.   

Abstract

Seventy-four Mycobacterium tuberculosis clinical isolates from China were subjected to drug susceptibility testing using ethambutol, isoniazid, rifampin, and ofloxacin. The results revealed that the presence of embB mutations did not correlate with ethambutol resistance but was associated with multiple-drug resistance, especially resistance to both ethambutol and rifampin.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17846128      PMCID： PMC2167975          DOI： 10.1128/AAC.00416-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community.

Authors:  A Van Rie ; R Warren; I Mshanga; A M Jordaan; G D van der Spuy ; M Richardson; J Simpson; R P Gie; D A Enarson; N Beyers; P D van Helden ; T C Victor
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Authors:  S Sreevatsan; K E Stockbauer; X Pan; B N Kreiswirth; S L Moghazeh; W R Jacobs; A Telenti; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.

Authors:  Ann S G Lee; Siti Noor Khadijah Othman; Yu Min Ho; Sin Yew Wong
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach.

Authors:  H Rinder; K T Mieskes; E Tortoli; E Richter; M Casal; M Vaquero; E Cambau; K Feldmann; T Löscher
Journal:  Mol Cell Probes       Date:  2001-02       Impact factor: 2.365

5.  Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.

Authors:  Ruiru Shi; Jianyuan Zhang; Chuanyou Li; Yuko Kazumi; Isamu Sugawara
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

6.  Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis.

Authors:  Tatjana Tracevska; Inta Jansone; Anda Nodieva; Olgerts Marga; Girts Skenders; Viesturs Baumanis
Journal:  Res Microbiol       Date:  2004-12       Impact factor: 3.992

7.  High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology.

Authors:  E Mazars; S Lesjean; A L Banuls; M Gilbert; V Vincent; B Gicquel; M Tibayrenc; C Locht; P Supply
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.

Authors:  Igor Mokrousov; N Vijaya Bhanu; Philip N Suffys; Gururaj V Kadival; Sook-Fan Yap; Sang-Nae Cho; Annemarie M Jordaan; Olga Narvskaya; Urvashi B Singh; Harrison M Gomes; Hyeyoung Lee; Savita P Kulkarni; Kuo-Chieh Lim; Baldip K Khan; Dick van Soolingen; Thomas C Victor; Leo M Schouls
Journal:  J Microbiol Methods       Date:  2004-06       Impact factor: 2.363

9.  Mode of action of ethambutol.

Authors:  M FORBES; N A KUCK; E A PEETS
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

10.  Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing.

Authors:  Igor Mokrousov; Tatiana Otten; Boris Vyshnevskiy; Olga Narvskaya
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
View more
  11 in total

1.  Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China.

Authors:  Qing Sun; Tong-Yang Xiao; Hai-Can Liu; Xiu-Qin Zhao; Zhi-Guang Liu; Ya-Nan Li; Hao Zeng; Li-Li Zhao; Kang-Lin Wan
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Mycobacterium tuberculosis embB codon 306 mutations confer moderately increased resistance to ethambutol in vitro and in vivo.

Authors:  Claudia Plinke; Kerstin Walter; Sahar Aly; Stefan Ehlers; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

3.  Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant mycobacterium tuberculosis isolates from China.

Authors:  Li-Li Zhao; Qing Sun; Hai-Can Liu; Xiao-Cui Wu; Tong-Yang Xiao; Xiu-Qin Zhao; Gui-Lian Li; Yi Jiang; Chun-Yan Zeng; Kang-Lin Wan
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

4.  Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Authors:  Angela M Starks; Aysel Gumusboga; Bonnie B Plikaytis; Thomas M Shinnick; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

5.  Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.

Authors:  Hassan Safi; Brendan Sayers; Manzour H Hazbón; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

6.  Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance.

Authors:  Chee Sian Kuan; Chai Ling Chan; Su Mei Yew; Yue Fen Toh; Jia-Shiun Khoo; Jennifer Chong; Kok Wei Lee; Yung-Chie Tan; Wai-Yan Yee; Yun Fong Ngeow; Kee Peng Ng
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

7.  Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.

Authors:  Zofia Bakuła; Agnieszka Napiórkowska; Jacek Bielecki; Ewa Augustynowicz-Kopeć; Zofia Zwolska; Tomasz Jagielski
Journal:  Biomed Res Int       Date:  2013-12-11       Impact factor: 3.411

8.  Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.

Authors:  Suporn Pholwat; Jie Liu; Suzanne Stroup; Jean Gratz; Sayera Banu; S M Mazidur Rahman; Sara Sabrina Ferdous; Suporn Foongladda; Duangjai Boonlert; Oleg Ogarkov; Svetlana Zhdanova; Gibson Kibiki; Scott Heysell; Eric Houpt
Journal:  MBio       Date:  2015-02-24       Impact factor: 7.867

9.  Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression.

Authors:  Parvinder Kaur; Saurabh Agarwal; Santanu Datta
Journal:  PLoS One       Date:  2009-06-15       Impact factor: 3.240

10.  Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States.

Authors:  Mitchell A Yakrus; Jeffrey Driscoll; Allison McAlister; David Sikes; Denise Hartline; Beverly Metchock; Angela M Starks
Journal:  Tuberc Res Treat       Date:  2016-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.